Oroantral Fistula Clinical Trial
Official title:
Lecturer of Oral &Maxillofacial Surgery
Verified date | November 2023 |
Source | Tanta University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ten patients with displaced root in maxillary sinus will be included in this study. the root will be recieved via lateral bony window in maxillary sinus wall using peizoelectric device then the bony window will be repositioned in its place.The patients will be received, clinically and radiologically examined, managed and followed up at the Oral and Maxillofacial surgery Department, Faculty of Dentistry, Tanta University
Status | Completed |
Enrollment | 10 |
Est. completion date | September 30, 2023 |
Est. primary completion date | July 21, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 55 Years |
Eligibility | Inclusion Criteria: root displaced in maxillary sinus absence of infection Exclusion Criteria: - • patients taking medications that affect bone healing - patients underwent head and neck radiotherapy |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Dentistry, Tanta University | Tanta |
Lead Sponsor | Collaborator |
---|---|
Tanta University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 1. degree of pain evaluated clinically | using visual analogue scale:0 represent no pain and 10 represents the highest level of pain | one-two weeks | |
Primary | soft tissue healing evaluated clinically | presence of dehiscence and exposure of bone or not | one- two week | |
Primary | the position of bony window evaluated radiographically | using panoramic view to evaluate the precise position of bony window | one week | |
Primary | bony window osteointegration and density evaluated radiographically | CT scan will be used using hounsfield units to evaluate density >1250 D1 850-1250 D2 350-850 D3 150-350 D4 | four months | |
Secondary | inflammation clinically | 0 no inflammation 1-3 mild inflammation 4-7 moderate inflammation 8-10 sever inflammation 0 no inflammation 1-3 mild inflammation 4-7 moderate inflammation 8-10 sever inflammation 0 no inflammation 1-3 mild inflammation 4-7 moderate inflammation 8-10 sever inflammation | one week |